Sign up Australia
Proactive Investors - Run By Investors For Investors

MGC Pharmaceuticals is the ASX Volume Leader at the end of the session

MGC Pharmaceuticals is the ASX Volume Leader at the end of the session.
MGC Pharmaceuticals is the ASX Volume Leader at the end of the session
MGC Pharmaceuticals is the ASX Volume Leader at the end of the session
Company Name Code Last Change Volume
MGC Pharmaceuticals MXC $0.100 35.14% 80,520,661
Atlas Iron AGO $0.035 0% 70,415,790
Pilot Energy PGY $0.002 100% 55,539,574
Botanix Pharmaceuticals BOT $0.064 28% 52,365,422
Zelda Therapeutics ZLD $0.071 18.33% 49,203,004
King River Copper KRC $0.006 20% 44,580,077
Magnum Gas & Power MPE $0.001 0% 43,234,314
Queensland Bauxite QBL $0.016 33.33% 41,623,683
Segue Resources SEG $0.002 0% 28,152,699
Hill End Gold HEG $0.002 0% 26,880,923

 

View full . profile View Profile

Proactive Investors Australia Timeline

Related Articles

Cello
April 16 2018
Global pharmaceutical R&D is forecast to reach $182bn by 2022 having grown at near 4% annually since 2006
Throne of Glass
April 30 2018
Rowling, Rowling, Rowling ... keep those titles rolling. Mind you, it's not all about Ms Rowling; Sarah J Maas title revenues grew 47% in the first half of the financial year and dieters are gorging on Tom Kerridge's books
Media junkie
February 14 2018
In modern parlance, Ebiquity is making a pivot towards becoming the "world's leading tech-enabled marketing and media analytics consultancy"

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use